deltatrials
Terminated PHASE2 NCT00004466

Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions Hyperlipidemia Nephrotic Syndrome
Interventions Atorvastatin Placebo
Updated 6 times since 2017 Last updated: Sep 14, 2017 Started: Oct 31, 1998 Primary completion: Dec 31, 1999 Completion: Dec 31, 1999

Listed as NCT00004466, this PHASE2 trial focuses on Hyperlipidemia and Nephrotic Syndrome and remains terminated or withdrawn. Sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), it has been updated 6 times since 1998, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  5. Oct 2017 — Jun 2018 [monthly]

    Terminated PHASE2

    Status: Completed → Terminated · Phase: NA → PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Oct 2017 [monthly]

    Completed NA

    First recorded

Oct 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Southwest Pediatric Nephrology Study Group
Data source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Dallas, United States